Karuna Stock Surges. Bristol Myers Buying Drug Developer for $14 Billion: Report
1 min read
Bristol Myers Squibb
agreed to buy
drug developer Karuna Therapeutics for $14 billion.
2023-12-22 07:25:00
All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator
Read more from original source here…